![Quiver Logo](/static/img/logo-icon.png)
![RNLX logo](https://quiver-logos.s3.us-east-2.amazonaws.com/rnlx.png)
Renalytix plc American Depositary Shares
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RNLX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of RNLX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RNLX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to RNLX
Recent picks made for RNLX stock on CNBC
ETFs with the largest estimated holdings in RNLX
Flights by private jets registered to RNLX
![Quiver Logo](/static/img/logo-icon.png)